UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q1 2020. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $10,070,000 | -19.2% | 500,000 | -9.1% | 2.03% | -22.5% |
| Q4 2022 | $12,468,500 | +53.5% | 550,000 | +27.0% | 2.62% | +65.8% |
| Q3 2022 | $8,123,000 | +23.4% | 433,000 | +22.6% | 1.58% | +16.5% |
| Q2 2022 | $6,582,000 | +114.3% | 353,106 | +107.7% | 1.35% | +69.5% |
| Q1 2022 | $3,072,000 | +48.1% | 170,000 | +70.0% | 0.80% | +39.2% |
| Q4 2021 | $2,074,000 | -47.4% | 100,000 | +81.8% | 0.57% | -62.6% |
| Q4 2019 | $3,941,000 | – | 55,000 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |